Phibro Animal Health Corporation (PAHC)
NASDAQ: PAHC · Real-Time Price · USD
39.16
-1.61 (-3.95%)
At close: Dec 5, 2025, 4:00 PM EST
38.50
-0.66 (-1.70%)
After-hours: Dec 5, 2025, 7:35 PM EST
Phibro Animal Health Stock Forecast
Stock Price Forecast
According to 4 professional analysts, the 12-month price target for Phibro Animal Health stock ranges from a low of $22 to a high of $50. The average analyst price target of $31.25 forecasts a -20.20% decrease in the stock price over the next year.
Price Target: $31.25 (-20.20%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Phibro Animal Health stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $45 → $50 | Buy | Maintains | $45 → $50 | +27.68% | Nov 7, 2025 |
| B of A Securities | B of A Securities | Sell Maintains $19 → $27 | Sell | Maintains | $19 → $27 | -31.05% | Aug 29, 2025 |
| JP Morgan | JP Morgan | Hold → Buy Upgrades $25 → $35 | Hold → Buy | Upgrades | $25 → $35 | -10.62% | Jul 7, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $21 → $26 | Hold | Maintains | $21 → $26 | -33.61% | Jun 25, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $20 → $21 | Hold | Maintains | $20 → $21 | -46.37% | May 8, 2025 |
Financial Forecast
Revenue This Year
1.50B
from 1.30B
Increased by 15.34%
Revenue Next Year
1.54B
from 1.50B
Increased by 3.28%
EPS This Year
2.79
from 1.19
Increased by 134.86%
EPS Next Year
3.08
from 2.79
Increased by 10.13%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.6B | 1.6B | |
| Avg | 1.5B | 1.5B | |
| Low | 1.4B | 1.5B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 19.7% | 7.0% | |
| Avg | 15.3% | 3.3% | |
| Low | 10.0% | -2.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.94 | 3.23 | |
| Avg | 2.79 | 3.08 | |
| Low | 2.61 | 2.85 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 147.1% | 15.7% | |
| Avg | 134.9% | 10.1% | |
| Low | 119.1% | 2.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.